These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3521617)

  • 1. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation.
    Diamantis W; Kohlhepp WC; Haertlein B; Melton J; Sofia RD
    Thromb Haemost; 1978 Aug; 40(1):24-36. PubMed ID: 103240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
    Hart S; Deniz A; Sommer B; Kietzmann M; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 Dec; 102(12):476-80. PubMed ID: 8591748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole inhibits in vivo rat platelet aggregation by a release of prostacyclin-like factor.
    Pinto A; Sorrentino R; Sorrentino L
    Gen Pharmacol; 1990; 21(2):255-9. PubMed ID: 2110089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of the novel anti-platelet aggregating agent 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid.
    Fujimori T; Harada K; Saeki T; Kogushi M; Akasaka K; Yamagishi Y; Yamatsu I
    Arzneimittelforschung; 1987 Oct; 37(10):1143-8. PubMed ID: 3124862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of oral hypoglycaemic sulfonyl ureas on prostacyclin release by the rat thoracic aorta.
    el Tahir KE; Ali AE; Abu Nasif MA; Ageel AM; Gadkarim EA
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):134-40. PubMed ID: 3099669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to carbon monoxide or to nicotine does not inhibit PGI2 formation by rat arterial rings incubated with human platelet-rich plasma.
    Hartiala J; Simberg N; Uotila P
    Artery; 1982; 10(6):412-9. PubMed ID: 6760833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H
    Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octahydroindolo[2,3-a]quinolizines and 3,4-dihydro-beta-carbolines as new inhibitors of human platelet aggregation.
    Blaskó G; Blaskó G; Szántay C
    Arzneimittelforschung; 1987 Jun; 37(6):667-9. PubMed ID: 3311053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modifications of platelet function induced by ASA. I. Effects on aggregation].
    Piro F; Capetti P
    Boll Soc Ital Biol Sper; 1979 Sep; 55(18):1895-901. PubMed ID: 553563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil and the synthesis of prostacyclin in human veins.
    Fahr A; Langer R; Sziegoleit W; Blauschmidt J; Albert H; Liebal H; Mest HJ
    Pharmazie; 1991 Mar; 46(3):213-4. PubMed ID: 1881946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of flupirtine on prostaglandin formation and platelet aggregation in vitro.
    Darius H; Schrör K
    Arzneimittelforschung; 1985; 35(1):55-9. PubMed ID: 3885962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a PGI2-like activity by deendothelialized rat aorta.
    Ts'ao CH; Holly CM; Serieno MA; Galluzzo TS
    Thromb Haemost; 1979 Oct; 42(3):873-84. PubMed ID: 388719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
    Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
    J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.